New shot aims to fight fat in early human test
Disease control
Completed
This early-stage study tested a new injectable drug, TE-8105, for weight loss in overweight or obese adults without diabetes. The main goals were to check if the drug is safe, how the body handles it, and if it affects body weight. Researchers gave single and multiple doses to 38…
Phase: PHASE1, PHASE2 • Sponsor: Immunwork, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC